European Leukemia Trial Registry
Trial: AML 96

More Details
Short Title AML 96
Trialgroup DSIL
Type of Trial multicentric, randomized
Disease Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age <= 60 years
Status Closed
Start of Recruitment 01.03.2000
Leader Ehninger, Prof. Dr. med., Gerhard
Contactperson

General Contact Person
Lerche, Linda
Tel: +49 (0)351 458 4251

General Contact Person
Soucek, Silke
Tel: +49 (0)351 458 4251
Fax: +49 (0)351 458 4367
Email: silke.soucek@uniklinikum-dresden.de

General Contact Person
Schaich, Prof. Dr. med., Markus
Tel: +49 (0)7195 591-39240
Fax: +49 (0)7195 591-939240
Email: markus.schaich@rems-murr-kliniken.de

Centre of Trial Universitätsklinikum Carl Gustav Carus, Dresden
Shortprotocol Shortprotocol
Diagnostics

Central diagnostics
Hämatologisches Labor, Universitätsklinikum Dresden

Molecular Genetics
Institut für Immunologie und Genetik, Kaiserslautern

created 13.07.2006 Anja Hellenbrecht
changed 24.09.2013 Sina Hehn
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org